So, for about half a century, theres been healthy skepticism about new-kid-on-the-block obesity drugs promising profound weight loss, only to see one after another fail and flop
The possibility that GLP-1 might hold potential for weight loss was not a new concept
Klinger, DBA, MS, RD, CPT Medical Reviewer Sylvia Klinger, DBA, MS, RD, CPT, is an internationally recognized nutrition expert who is relentlessly passionate about helping people fall in love with creating and enjoying deli
A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
Not thinking about food between meals
"GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications"